Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats
RatSpinal cord injury
Extraction: mesh. Machine-extracted fields require source verification.
PRECLINICAL PUBLICATION · 2007
Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats
Rat / Spinal cord injury
Evidence by therapy association
Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.